OTC:SIGY | Free Cash Flow | Sigyn Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2025-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-03-31-$294,446.00
2024-12-31-$290,218.00
2024-03-31-$235,612.00
2023-12-31-$127,894.00
2023-03-31-$562,573.00
2022-12-31-$451,767.00$0.00-$451,767.00
2022-03-31-$459,571.00
2021-12-31-$552,961.00$9,059.00-$562,020.00
2021-03-31-$274,424.00$2,871.00-$277,295.00
2020-12-31-$280,753.00
2020-03-31-$212,251.00
2019-12-31-$30,010.00
2019-03-31-$72,833.00
2018-12-31$12,321.00$2,090.00$10,231.00
2018-03-31-$321,841.00
2017-12-31-$218,952.00$0.00-$218,952.00
2017-03-31-$107,964.00$470.00-$108,434.00
2016-03-31-$317,569.00$3,283.00-$320,852.00
2015-12-31-$78,284.00
2015-03-31-$7.00
2014-12-31$1,157.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2024-12-31-$872,436.00
2023-12-31-$1.38M
2022-12-31-$1.83M$860.00-$1.83M
2021-12-31-$1.77M$29,264.00-$1.8M
2020-12-31-$829,809.00
2019-12-31-$143,684.00
2018-12-31-$286,112.00$2,950.00-$289,062.00
2017-12-31-$400,003.00$940.00-$400,943.00
2015-12-31-$83,820.00$2,451.00-$86,271.00
2014-12-31-$44,440.00$3,465.00-$47,905.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.